D
Rhythm Pharmaceuticals, Inc. RYTM
$50.97 $0.731.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -260.60M -258.94M -259.43M -273.87M -184.68M
Total Depreciation and Amortization 1.56M 1.60M 1.65M 1.71M 1.76M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 134.59M 123.65M 126.33M 131.83M 41.96M
Change in Net Operating Assets 10.58M 9.28M 3.00M -135.00K 4.81M
Cash from Operations -113.88M -124.42M -128.45M -140.47M -136.16M
Capital Expenditure -- 1.00K 0.00 0.00 -47.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -48.17M -46.69M -50.83M 5.92M -5.62M
Cash from Investing -48.17M -46.69M -50.83M 5.92M -5.67M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 56.39M 19.25M 64.27M 63.20M 57.40M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock 138.85M 138.85M 138.85M -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -4.00M -2.77M 22.77M 15.54M 16.97M
Cash from Financing 191.24M 155.34M 225.89M 78.74M 74.37M
Foreign Exchange rate Adjustments 2.00K -1.17M -487.00K -299.00K -142.00K
Miscellaneous Cash Flow Adjustments 0.00 -1.00K -- -- --
Net Change in Cash 29.19M -16.94M 46.12M -56.10M -67.60M
Weiss Ratings